In January of this year, the FDA noted that it had "received adverse event reports after patients used compounded semaglutide" and that "patients should not use a compounded drug if an approved drug is available to treat a patient." In July, the agency followed up with a notice that it had "received reports of adverse events, some requiring hospitalization, that may be related to overdoses due to dosing errors associated with compounded semaglutide injectable products." And in August, Eli Lilly, the maker of Zepbound and Mounjaro, sent a series of cease-and-desist letters to providers urging them to stop prescribing compounded versions of those drugs
Rybelsus Rybelsus is an oral version of semaglutide that's taken as a tablet once a day
Your GP will calculate a NAFLD Fibrosis Score (NFS) or FIB-4 score using your age, BMI, blood test results, and other factors to estimate your risk of advanced liver fibrosis
Terminal Sterilization (If Applicable) In certain validated cases, terminal sterilization may be applied
Does your cat have a chronic gastrointestinal problem